Flexible, ingenious, professional and with an approach that focuses on teamwork, we are a leading European intellectual property firm
We are currently recruiting for our Autumn 2019 trainee positions for graduates with backgrounds in Electronics, Computer Sciences and Mechanical Engineering, or related disciplines. We are particularly interested in graduates with higher level qualifications in artificial intelligence and machine learning to support the tremendous growth that we are seeing in this field.
The circumstances in which clinical data concerning authorised medicinal products can be disclosed by the European Medicines Agency (EMA), continues to generate debate. In the recent case of Amicus Therapeutics v European Medicines Agency (EMA) (Case T-33/17), the General Court (Second Chamber) of the European Union has confirmed that there is no general presumption of confidentiality of certain categories of documents submitted in the context of a marketing authorisation application, and in particular clinical study reports.
"Venner Shipley has been doing an excellent job for us, managing and developing a portfolio of assets."
The European Patent Office (EPO) has announced that there will be a number of fee changes coming into effect from 1 April 2018. There is no general fee increase as there has been in line with inflation in previous years, however a number of official fees will be affected and there could be a substantial cost saving by taking the following into consideration before 1 April 2018:
Features a roundup of the latest cases and development in IP.
